Asia-Pacific Self-Monitoring Blood Glucose Devices Market Share

Statistics for the 2023 & 2024 Asia-Pacific Self-Monitoring Blood Glucose Devices market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Self-Monitoring Blood Glucose Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Asia-Pacific Self-Monitoring Blood Glucose Devices Industry

The Asia-Pacific self-monitoring blood glucose devices market is fragmented with a few major manufacturers like Abbott, LifeScan, Roche, and Ascensia etc. gaining presence in major countries of the Asia-Pacific market, while the remaining market comprises other local or region-specific manufacturers.

Asia-Pacific Self-Monitoring Blood Glucose Devices Market Leaders

  1. I-Sens

  2. Abbott Diabetes Care

  3. Ascensia Diabetes Care

  4. LifeScan Inc.

  5. Roche Diabetes Care

*Disclaimer: Major Players sorted in no particular order

Asia-Pacific Self-Monitoring Blood Glucose Devices Market Concentration

Asia-Pacific Blood Glucose Self-monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)